• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高级别浆液性卵巢癌细胞在疾病进展过程中自发形成多细胞结构的能力与其在免疫抑制小鼠体内的原位致瘤性相关。

The Capacity of High-Grade Serous Ovarian Cancer Cells to Form Multicellular Structures Spontaneously along Disease Progression Correlates with Their Orthotopic Tumorigenicity in Immunosuppressed Mice.

作者信息

Goyeneche Alicia, Lisio Michael-Anthony, Fu Lili, Srinivasan Rekha, Valdez Capuccino Juan, Gao Zu-Hua, Telleria Carlos

机构信息

Experimental Pathology Unit, Department of Pathology, Faculty of Medicine, McGill University, Montreal, QC H3A 2B4, Canada.

Division of Basic Biomedical Sciences, Sanford School of Medicine, The University of South Dakota, Vermillion, SD 57069, USA.

出版信息

Cancers (Basel). 2020 Mar 16;12(3):699. doi: 10.3390/cancers12030699.

DOI:10.3390/cancers12030699
PMID:32188032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7140084/
Abstract

Many studies have examined the biology, genetics, and chemotherapeutic response of ovarian cancer's solid component; its liquid facet, however, remains critically underinvestigated. Floating within peritoneal effusions known as ascites, ovarian cancer cells form multicellular structures, creating a cancer niche in suspension. This study explores the pathobiology of spontaneously formed, multicellular, ovarian cancer structures derived from serous ovarian cancer cells isolated along disease evolution. It also tests their capacity to cause peritoneal disease in immunosuppressed mice. Results stem from an analysis of cell lines representing the most frequently diagnosed ovarian cancer histotype (high-grade serous ovarian cancer), derived from ascites of the same patient at distinct stages of disease progression. When cultured under adherent conditions, in addition to forming cellular monolayers, the cultures developed areas in which the cells grew upwards, forming densely packed multilayers that ultimately detached from the bottom of the plates and lived as free-floating, multicellular structures. The capacity to form foci and to develop multicellular structures was proportional to disease progression at the time of ascites extraction. Self-assembled in culture, these structures varied in size, were either compact or hollow, irregular, or spheroidal, and exhibited replicative capacity and an epithelial nature. Furthermore, they fully recreated ovarian cancer disease in immunosuppressed mice: accumulation of malignant ascites and pleural effusions; formation of discrete, solid, macroscopic, peritoneal tumors; and microscopic growths in abdominal organs. They also reproduced the histopathological features characteristic of high-grade serous ovarian cancer when diagnosed in patients. The following results encourage the development of therapeutic interventions to interrupt the formation and/or survival of multicellular structures that constitute a floating niche in the peritoneal fluid, which in turn halts disease progression and prevents recurrence.

摘要

许多研究都对卵巢癌实体成分的生物学、遗传学及化疗反应进行了探究;然而,其液体部分仍严重缺乏研究。卵巢癌细胞漂浮在被称为腹水的腹腔积液中,形成多细胞结构,在悬浮状态下营造出一个癌症微环境。本研究探索了源自沿疾病进展过程分离出的浆液性卵巢癌细胞的自发形成的多细胞卵巢癌结构的病理生物学。同时还测试了这些结构在免疫抑制小鼠中引发腹膜疾病的能力。研究结果源于对代表最常见诊断的卵巢癌组织类型(高级别浆液性卵巢癌)的细胞系的分析,这些细胞系取自同一患者在疾病进展不同阶段的腹水。在贴壁条件下培养时,这些细胞系除了形成细胞单层外,还形成了细胞向上生长的区域,形成紧密堆积的多层结构,最终从培养皿底部脱离,以自由漂浮的多细胞结构形式存在。形成病灶和发展多细胞结构的能力与抽取腹水时的疾病进展程度成正比。这些结构在培养中自行组装,大小各异,有致密的或中空的、不规则的或球形的,具有复制能力且呈上皮性质。此外,它们在免疫抑制小鼠中完全重现了卵巢癌疾病:恶性腹水和胸腔积液的积聚;离散的、实性的、肉眼可见的腹膜肿瘤的形成;以及腹部器官中的微观生长。当在患者中诊断时,它们还重现了高级别浆液性卵巢癌的组织病理学特征。以下研究结果促使人们开发治疗干预措施,以阻断构成腹膜液中漂浮微环境的多细胞结构的形成和/或存活,进而阻止疾病进展并预防复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/5dd303658f20/cancers-12-00699-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/0af32c99a5ed/cancers-12-00699-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/b1c3e5266535/cancers-12-00699-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/b8423fb090a0/cancers-12-00699-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/c5ca72413f09/cancers-12-00699-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/7d28de2fb822/cancers-12-00699-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/5475a67c4af9/cancers-12-00699-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/1b992a4de713/cancers-12-00699-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/75949986a131/cancers-12-00699-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/47359c22a53c/cancers-12-00699-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/5dd303658f20/cancers-12-00699-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/0af32c99a5ed/cancers-12-00699-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/b1c3e5266535/cancers-12-00699-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/b8423fb090a0/cancers-12-00699-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/c5ca72413f09/cancers-12-00699-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/7d28de2fb822/cancers-12-00699-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/5475a67c4af9/cancers-12-00699-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/1b992a4de713/cancers-12-00699-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/75949986a131/cancers-12-00699-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/47359c22a53c/cancers-12-00699-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c7/7140084/5dd303658f20/cancers-12-00699-g010.jpg

相似文献

1
The Capacity of High-Grade Serous Ovarian Cancer Cells to Form Multicellular Structures Spontaneously along Disease Progression Correlates with Their Orthotopic Tumorigenicity in Immunosuppressed Mice.高级别浆液性卵巢癌细胞在疾病进展过程中自发形成多细胞结构的能力与其在免疫抑制小鼠体内的原位致瘤性相关。
Cancers (Basel). 2020 Mar 16;12(3):699. doi: 10.3390/cancers12030699.
2
Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.间皮细胞与肿瘤细胞相互作用,以在腹腔积液中形成卵巢癌多细胞球体。
Clin Exp Metastasis. 2016 Dec;33(8):839-852. doi: 10.1007/s10585-016-9821-y. Epub 2016 Sep 9.
3
Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma.短期类器官培养用于高级别浆液性卵巢癌的药物敏感性测试。
Gynecol Oncol. 2020 Jun;157(3):783-792. doi: 10.1016/j.ygyno.2020.03.026. Epub 2020 Apr 4.
4
Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids.AKT 活性的调节与腹水来源的上皮性卵巢癌细胞球的可逆休眠有关。
Carcinogenesis. 2012 Jan;33(1):49-58. doi: 10.1093/carcin/bgr241. Epub 2011 Oct 31.
5
Inhibiting ULK1 kinase decreases autophagy and cell viability in high-grade serous ovarian cancer spheroids.抑制ULK1激酶可降低高级别浆液性卵巢癌球体中的自噬和细胞活力。
Am J Cancer Res. 2020 May 1;10(5):1384-1399. eCollection 2020.
6
Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays.利用悬滴阵列形成稳定的小细胞数量三维卵巢癌球体用于临床前药物敏感性测定。
Gynecol Oncol. 2015 Jul;138(1):181-9. doi: 10.1016/j.ygyno.2015.04.014. Epub 2015 Apr 22.
7
Malignant peritoneal effusion acting as a tumor environment in ovarian cancer progression: Impact and significance.恶性腹腔积液在卵巢癌进展中作为肿瘤微环境的作用、影响及意义
World J Clin Oncol. 2018 Dec 20;9(8):167-171. doi: 10.5306/wjco.v9.i8.167.
8
Development of a syngeneic mouse model of epithelial ovarian cancer.建立上皮性卵巢癌同源小鼠模型。
J Ovarian Res. 2010 Oct 19;3:24. doi: 10.1186/1757-2215-3-24.
9
Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006-2015.恶性腹水在初诊时最常发生于高级别浆液性乳头状卵巢癌患者:2006 年至 2015 年在拜罗伊特医院治疗的 191 名女性的回顾性分析。
Arch Gynecol Obstet. 2019 Feb;299(2):515-523. doi: 10.1007/s00404-018-4952-9. Epub 2018 Nov 10.
10
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.高级别浆液性晚期卵巢癌的BRCA突变状态、初始疾病表现及临床结局:一项多中心研究
Am J Obstet Gynecol. 2017 Sep;217(3):334.e1-334.e9. doi: 10.1016/j.ajog.2017.05.036. Epub 2017 May 23.

引用本文的文献

1
RHOV is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis.RHOV是一种对卵巢癌腹膜转移至关重要的可分离反应性Rho GTP酶。
bioRxiv. 2025 Aug 13:2025.08.12.669944. doi: 10.1101/2025.08.12.669944.
2
Rheological transition driven by matrix makes cancer spheroids resilient under confinement.基质驱动的流变学转变使癌症球体在受限条件下具有弹性。
Life Sci Alliance. 2025 Mar 27;8(6). doi: 10.26508/lsa.202402601. Print 2025 Jun.
3
Exploiting Cancer Dormancy Signaling Mechanisms in Epithelial Ovarian Cancer Through Spheroid and Organoid Analysis.

本文引用的文献

1
High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints.高级别浆液性卵巢癌:基础科学、临床和治疗观点。
Int J Mol Sci. 2019 Feb 22;20(4):952. doi: 10.3390/ijms20040952.
2
Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006-2015.恶性腹水在初诊时最常发生于高级别浆液性乳头状卵巢癌患者:2006 年至 2015 年在拜罗伊特医院治疗的 191 名女性的回顾性分析。
Arch Gynecol Obstet. 2019 Feb;299(2):515-523. doi: 10.1007/s00404-018-4952-9. Epub 2018 Nov 10.
3
Ovarian Carcinoma-Associated Mesenchymal Stem Cells Arise from Tissue-Specific Normal Stroma.
通过球体和类器官分析探索上皮性卵巢癌中的癌症休眠信号机制
Cells. 2025 Jan 17;14(2):133. doi: 10.3390/cells14020133.
4
Comparison of two-dimensional and three-dimensional culture systems and their responses to chemotherapy in cells representing disease progression of high-grade serous ovarian cancer.二维和三维培养系统的比较及其对代表高级别浆液性卵巢癌疾病进展的细胞中化疗的反应。
Biochem Biophys Rep. 2024 Oct 17;40:101838. doi: 10.1016/j.bbrep.2024.101838. eCollection 2024 Dec.
5
Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer cell lines and isogenic models.卵巢癌细胞系和同基因模型中的细胞内在铂反应以及相关的遗传和基因表达特征。
bioRxiv. 2024 Jul 29:2024.07.26.605381. doi: 10.1101/2024.07.26.605381.
6
Matriptase drives dissemination of ovarian cancer spheroids by a PAR-2/PI3K/Akt/MMP9 signaling axis.组织蛋白酶 M 通过 PAR-2/PI3K/Akt/MMP9 信号通路促进卵巢癌细胞球的扩散。
J Cell Biol. 2023 Nov 6;222(11). doi: 10.1083/jcb.202209114. Epub 2023 Sep 22.
7
Model of collective detachment in high-grade serous ovarian cancer demonstrates that tumor spheroids produce ECM to support metastatic processes.高级别浆液性卵巢癌中集体脱离模型表明,肿瘤球体产生细胞外基质以支持转移过程。
APL Bioeng. 2023 Feb 28;7(1):016111. doi: 10.1063/5.0132254. eCollection 2023 Mar.
8
The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone.高级别浆液性卵巢癌细胞的转移能力随疾病进展而变化:米非司酮的抑制作用。
Cancer Cell Int. 2022 Dec 9;22(1):397. doi: 10.1186/s12935-022-02822-5.
9
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer.多组学分析鉴定 CPT1A 为铂耐药性高级别浆液性卵巢癌的潜在治疗靶点。
Cell Rep Med. 2021 Dec 21;2(12):100471. doi: 10.1016/j.xcrm.2021.100471.
10
Nelfinavir Induces Cytotoxicity towards High-Grade Serous Ovarian Cancer Cells, Involving Induction of the Unfolded Protein Response, Modulation of Protein Synthesis, DNA Damage, Lysosomal Impairment, and Potentiation of Toxicity Caused by Proteasome Inhibition.奈非那韦对高级别浆液性卵巢癌细胞具有细胞毒性,涉及诱导未折叠蛋白反应、调节蛋白质合成、DNA损伤、溶酶体损伤以及增强蛋白酶体抑制所导致的毒性。
Cancers (Basel). 2021 Dec 26;14(1):99. doi: 10.3390/cancers14010099.
卵巢癌相关间充质干细胞来源于组织特异性正常基质。
Stem Cells. 2019 Feb;37(2):257-269. doi: 10.1002/stem.2932. Epub 2018 Nov 2.
4
Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics.建立用于新型疗法临床前评估的上皮性卵巢癌患者来源的肿瘤异种移植模型。
Clin Cancer Res. 2017 Mar 1;23(5):1263-1273. doi: 10.1158/1078-0432.CCR-16-1237. Epub 2016 Aug 29.
5
ARID1A gene mutation in ovarian and endometrial cancers (Review).卵巢癌和子宫内膜癌中的ARID1A基因突变(综述)
Oncol Rep. 2016 Feb;35(2):607-13. doi: 10.3892/or.2015.4421. Epub 2015 Nov 16.
6
Understanding the Unique Attributes of MUC16 (CA125): Potential Implications in Targeted Therapy.了解MUC16(CA125)的独特属性:靶向治疗中的潜在意义。
Cancer Res. 2015 Nov 15;75(22):4669-74. doi: 10.1158/0008-5472.CAN-15-1050. Epub 2015 Nov 2.
7
Beyond genomics: critical evaluation of cell line utility for ovarian cancer research.超越基因组学:对卵巢癌研究中细胞系实用性的批判性评估。
Gynecol Oncol. 2015 Oct;139(1):97-103. doi: 10.1016/j.ygyno.2015.08.017. Epub 2015 Aug 29.
8
In vivo tumor growth of high-grade serous ovarian cancer cell lines.高级别浆液性卵巢癌细胞系的体内肿瘤生长情况
Gynecol Oncol. 2015 Aug;138(2):372-7. doi: 10.1016/j.ygyno.2015.05.040. Epub 2015 Jun 5.
9
Spherical cancer models in tumor biology.肿瘤生物学中的球形癌症模型。
Neoplasia. 2015 Jan;17(1):1-15. doi: 10.1016/j.neo.2014.12.004.
10
Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes.卵巢癌细胞系面板(OCCP):体外形态学亚型的临床重要性。
PLoS One. 2014 Sep 17;9(9):e103988. doi: 10.1371/journal.pone.0103988. eCollection 2014.